health boards; retaliation; prohibition
HB 2209 would add a new section to Arizona law governing health profession regulatory boards to prohibit retaliation against certain “protected individuals.” Covered individuals include health professionals, applicants for licensure or certification, residents, fellows, clinical trainees, and people assisting them. The bill protects disclosures made in good faith about violations of law, misuse of regulatory authority, fraud, waste, unethical conduct, politically or ideologically motivated enforcement, threats to patient safety, or interference with oversight. It also protects participation in investigations or hearings, refusal to engage in unlawful conduct, seeking legal counsel, and assisting others in making disclosures.
The bill creates a framework for proving retaliation, including a prima facie case if a retaliatory action occurs within two years of a protected disclosure, and it shifts the burden to the board to show by clear and convincing evidence that the action would have occurred anyway. It authorizes the attorney general and county attorneys to investigate, subpoena records, and file civil actions, and it allows protected individuals to sue directly in superior court. Available remedies include reinstatement or restoration of licensure, correction of records, injunctive relief, actual and compensatory damages, civil penalties up to $25,000 per violation, attorney fees, interest, and punitive damages. The bill also requires confidentiality of the disclosing person’s identity except in limited circumstances.
HB 2209 would create a new statutory cause of action and enforcement scheme in Title 32 for alleged retaliation by health profession regulatory boards. It would expand oversight authority for the attorney general and county attorneys, establish evidentiary standards and a three-year limitations period, and require boards to preserve confidentiality of protected individuals. The measure could affect licensing, disciplinary, and investigative practices of Arizona health profession boards by limiting actions that could be viewed as retaliatory and exposing boards to civil liability and monetary penalties.
Based on the bill text and the absence of committee discussion or recorded votes, the available context suggests the measure is framed as a protections-and-accountability bill for health professionals and whistleblowers rather than a controversial regulatory expansion. Its language indicates concern about inconsistent enforcement, politically motivated actions, and misuse of board authority, implying support from those who believe boards need stronger limits on retaliation. No contrary testimony or vote history is provided, so there is no documented opposition in the supplied materials.
The main points of contention are likely to be the scope of who qualifies as a protected individual, what counts as a protected disclosure, and how broadly retaliatory action is defined. Health profession regulatory boards may object to the bill’s burden-shifting framework, the clear-and-convincing evidence standard, and the ability of individuals to sue directly for broad remedies including punitive damages and civil penalties. Supporters would likely emphasize whistleblower protections, due process, and safeguards against politically or ideologically motivated enforcement, while critics may argue the bill could chill legitimate disciplinary oversight and investigations.